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Background: In this study, we screened and identiﬁed an endophyte JG09 having strong biocatalytic
activity for ginsenosides from Platycodon grandiﬂorum, converted ginseng total saponins and ginsenoside
monomers, determined the source of minor ginsenosides and the transformation pathways, and calcu-
lated the maximum production of minor ginsenosides for the conversion of ginsenoside Rb1 to assess the
transformation activity of endophyte JG09.
Methods: The transformation of ginseng total saponins and ginsenoside monomers Rb1, Rb2, Rc, Rd, Rg1
into minor ginsenosides F2, C-K and Rh1 using endophyte JG09 isolated by an organizational separation
method and Esculin-R2A agar assay, as well as the identiﬁcation of transformed products via TLC and
HPLC, were evaluated. Endophyte JG09 was identiﬁed through DNA sequencing and phylogenetic
analysis.
Results: A total of 32 b-glucosidase-producing endophytes were screened out among the isolated 69
endophytes from P. grandiﬂorum. An endophyte bacteria JG09 identiﬁed as Luteibacter sp. effectively
converted protopanaxadiol-type ginsenosides Rb1, Rb2, Rc, Rd into minor ginsenosides F2 and C-K, and
converted protopanaxatriol-type ginsenoside Rg1 into minor ginsenoside Rh1. The transformation
pathways of major ginsenosides by endophyte JG09 were as follows: Rb1/Rd/F2/C-K; Rb2/C-
O/C-Y/C-K; Rc/C-Mc1/C-Mc/C-K; Rg1/Rh1. The maximum production rate of ginsenosides F2
and C-K reached 94.53% and 66.34%, respectively.
Conclusion: This is the ﬁrst report about conversion of major ginsenosides into minor ginsenosides by
fermentation with P. grandiﬂorum endophytes. The results of the study indicate endophyte JG09 would be
a potential microbial source for obtaining minor ginsenosides.
Copyright 2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ginseng, the root of Panax ginseng Meyer (Araliaceae), has been
a greatly valued herb in Asian countries for over 1,000 yr [1]. It
consists of ginsenosides, polysaccharides, polyynes, ﬂavonoids, and
volatile oils among other components [2]. Ginsenosides are
considered the major active components of ginseng species and are
responsible for numerous pharmacological properties, such as
antitumor, anti-aging, blood vessel softening, anticancer, anti-
inﬂammatory, and hepatoprotective effect activities [3e5]. Degly-
cosylated ginsenosides (minor ginsenosides Rh1, Rh2, F2, Rg3, C-K,esources of Changbai Mountain an
ht 2016, The Korean Society of Gi
/4.0/).etc.) are more pharmaceutically active than major glycosylated
ginsenosides (Rb1, Rb2, Rc, Rd, Rg1, etc.), because of their smaller
size, higher bioavailability, and better permeability across the cell
membrane [6]. However, minor ginsenosides are not present in
most natural ginseng plants or are present in very low amounts.
Therefore, the study of converting major ginsenosides to minor
ginsenosides is of great signiﬁcance [7]. Various approaches
including heating [8], acid treatment [9], and biotransformation
[10] have been carried out. Among these methods, biotransforma-
tion is shown to be the most effective way to produce minor gin-
senosides [9,11,12]. Biotransformation is a high speciﬁcity, low cost,d Functional Molecules, Ministry of Education, Yanbian University, Gongyuan Road
nseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
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deﬁned as chemical reactions catalyzed by different enzymes of
various microbial cells; it can be an alternative for biosynthesis of
some important drug metabolites. It also exhibits many advantages
over chemical synthesis such as stereo- or region-selectivity, mild
reaction conditions, and avoiding complex protection and depro-
tection steps [13,14].
Endophytes are considered to be bacterial or fungal microor-
ganisms that colonize healthy plant tissues without causing any
apparent symptoms [15]. Recently, the application of endophytes to
biotransformation has also attracted people’s attention. Due to the
endophytes special living environment and long term coexistence
with their hosts, the endophytes have developed a speciﬁc lifestyle
to maintain a stable symbiosis, and they can produce various
extracellular enzymes for secondary metabolite biosynthesis.
Therefore, endophytes have been used for some complex reactions
to obtain more active compounds instead of traditional chemical
methods [16]. The application of endophytes to biotransformation
of region- and stereo-selective production is a suitable method to
obtain more active substances; they have been used in natural
compound conversion such as ﬂavans, tetrahydrofuran lignin, and
astragalosides [17e19].
To date, however, no relevant studies have been reported on the
conversion of major ginsenosides to minor ginsenosides by endo-
phytes isolated from Platycodon grandiﬂorum. The present study
aimed to enhance the content of minor ginsenosides in ginseng
total saponins by endophytes from P. grandiﬂorum. The optimiza-
tion of the bioconversion conditions was conducted by single factor
tests of the bioconversion procedure.
2. Materials and methods
2.1. Materials
HPLC-grade methanol and acetonitrile (ACN) were supplied by
Merck (Darmstadt, Germany). Ultrapure water was prepared by a
Milli-Q puriﬁcation system (Millipore, Bedford, MA, USA). Ginse-
nosides Rb1, Rb2, Rc, Rd, Rg1, Rg3, Rh1, Rh2, Re, F2, C-K and PPD
were purchased from Chengdu Mann Stewart Biological Technol-
ogy Co., Ltd. (Sichuan, China). The other chemicals used in this
study were at least of analytical reagent grade.
2.2. Standard solutions and standard curve preparation
Stock solutions in methanol were prepared for ginsenosides F2
and C-K in concentrations of 2.0 mg/mL and 3.0 mg/mL, respec-
tively. The stock solutions were then diluted with methanol to yield
a series of standard solutions with different concentrations for
linearity validation and standard curve preparation. Working
methanolic solutions were prepared daily from stock solutions.
2.3. Isolation and screening of b-glucosidase-producing endophytes
Plant samples were obtained from a P. grandiﬂorum ﬁeld in Yanji,
China. The P. grandiﬂorum was kept refrigerated at 4C, and endo-
phytes were isolated within 48 h.
The P. grandiﬂorum samples were washed adequately under
running tap water to remove soil, then surface-disinfected through
the following sequence of immersions: 1min in 70% (v/v) ethanol,
5e10 min in 5% NaClO, 1 min in 70% (v/v) ethanol, and 1 min in
sterilewater four times. The outer tissuewas removedwith a sterile
scalpel. Small segments (0.5 cm  0.5 cm) were cut and pressed on
a potato dextrose agar plates (PDA), R2A (Agar medium S) agar
plates and Luria-Bertani (LB) agar plates and incubated at 30C for5e7 d. Single colonies from these plates were puriﬁed by trans-
ferring onto new plates.
Esculin-R2A agar was used to isolate b-glucosidase-producing
endophytes. The endophytes producing b-glucosidase that hydro-
lyze esculin appeared as colonies surrounded by a reddish-brown
to dark brown zone. Esculin-R2A agar contains (per 1 L): esculin
1 g and ferric citrate 0.5 g with 15.2 g R2A agar, autoclaved at 121C
for 15 min.
2.4. Bioconversion of major ginsenosides in ginseng total saponins
2.4.1. Transformation of ginseng total saponins
The b-glucosidase-producing endophytes were cultured in LL
medium consisting of 0.5 g/L NH4Cl, 1.0 g/L K2HPO4, 0.5 g/L KH2PO4,
0.25 g/L MgSO4, and 1.0 g/L yeast extract. The medium was steril-
ized at 121C for 15 min, and the initial pH was 7.0. The suspension
of the strain was incubated until it reached logarithmic phase
growth, then mixed with the same volume of 15 mg/L ginseng total
saponins solution and incubated in a shaking incubator (30C,
150 rpm). The culture was extracted with the same volume of
aqueous saturated n-BuOH and concentrated in a vacuum to dry-
ness, then the residue was dissolved in methanol and analysis of
the biotransformation ability of ginsenosides was carried out by
TLC.
In order to explore the source of minor ginsenosides and the
conversion pathway by endophytes, we mixed the suspension
culture of endophytes and ginsenosides Rb1, Rb2, Rc, Rd, and Rg1
and conﬁrmed at regular intervals by TLC and HPLC analysis.
2.4.2. Optimization of fermentation conditions
Microbial fermentation requires a suitable fermentation me-
dium, temperature and pH. The optimum fermentation condition is
the key to getting a high yield of fermentation products success-
fully; in order to obtain the best conversion for ginsenosides,
single-factor experiments were performed to optimize themedium
and pH value. Six culturemediums (H2O, R2A, PDB (Potato Dextrose
Broth), LB (Luria-Bertani), NB (Nutrient Broth), LL (Lysogeny Liquid),
initial pH of 7.0) were tested one by one. Subsequently, fermenta-
tion conditions, on the basis of the optimum medium, at pH values
of 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0 were investigated.
2.5. Analytic methods
2.5.1. TLC analysis
TLC was carried out using 60F254 silica gel plates (Merck) with
CHCl3eCH3OHeH2O (10:5:1, v/v/v, lower phase) as the solvent. The
spots on the TLC plates were visualized by spraying with 10% (v/v)
H2SO4 solution, followed by heating at 110C for 5 min.
2.5.2. HPLC analysis
HPLC analysis was performed using an HPLC system with auto-
matic injector and single wavelength UV detector. The separation
was carried out on a BDS HYPERSIL C18 (5 mm, 250 mm  4.6 mm;
Agilent 1100, Waltham, USA) with a column temperature of 25C.
The mobile phase was A (water) and B (acetonitrile). Gradient
elution started with 77% solvent A and 23% solvent B and was then
changed to: A from 77% to 54%, 0e13 min; A from 54% to 32%, 13e
33min; A from 32% to 0%, 45e55min; A from 0% to 77%, 60e63min.
The ﬂow rate was 1.0 mL/min, and samples were detected by ab-
sorption at 203 nm, with an inject volume of 10 mL.
2.6. Phylogenetic analysis
The endophyte genomic DNA was extracted by the method of
CTAB (Hexadecyl trimethyl ammonium Bromide) [20]. The 16S
Fig. 1. Gel electrophoresis of recombinant plasmid DNA of endophyte JG09.
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(50-AGAGTTTGATCCTGGCTCAG-30) and 1492R (50-GGTTACCTTGT-
TACGACTT-30) [21]. The PCR reaction system was carried out in
volumes of 20 mL, containing 2 mL of template DNA, 2 mL of each
primer, 2 mL of dNTPs, 2 mL of 10  PCR buffer (containing Plus
Mg2þ), 0.4 mL of TaKaRa Taq enzyme, and 10 mL of ddH2O. The
ampliﬁcation program was as follows: an initial denaturation at
95C for 3 min, 30 cycles of 95C for 30 s, 56C for 30 s, and 72C for
90 s, and a ﬁnal extension at 72C for 7 min.
The PCR products were puriﬁed using a Silica Bead DNA Gel
Extraction Kit (Fermentas Life Sciences, Vilnius, Lithuania), in order
to obtain more complete sequence information, then ligated into a
pGEM-Teasy Vector (Bioﬁne, China), and subsequently used to
transform JM109 competent cells. Transformed cells carrying in-
serts were identiﬁed with blue/white colony selection. Recombi-
nant plasmids in transformed cells were cloned and then
sequenced (Shanghai Biotechnology Co., Ltd. Megiddo).
The obtained sequencing results were checked for homology
using the NCBI BLAST program (http://www.ncbi.nlm.nih.gov/
BLAST), and compared with available data from GenBank
sequence databases, getting the closest strain’s rDNA sequence. The
resulting alignment was used to construct a Neighbor-joining (NJ)
phylogenetic tree using MEGA 4.0 software (http://www.
megasoftware.net/mega4/mega.html) [22].3. Results and discussion
3.1. Isolation and phylogenetic analysis of b-glucosidase-producing
endophytes
A total of 69 endophytes were isolated from P. grandiﬂorum by
the method of organizational separation. After the Esculin-R2A
agar assay, 32 b-glucosidase-producing microorganisms were
assayed to verify their activity for converting ginseng total sapo-
nins. Among these endophytes, strain JG09 showed the strongest
activity for converting ginseng total saponins into minor ginseno-
sides C-K, F2 and Rh1.Table 1
Similarity between the isolates and closest species in GenBank
Strain ID Accession number Closest known species Similarity (%)
JG09 KC342052 Luteibacter sp. NORREL-Li2 99
FR727720 Luteibacter sp.
IMP04
99
JF778702 Luteibacter rhizovicinus strain HRT22 99The genomic DNA of strain JG09 was extracted and ampliﬁed,
recombined and sequenced. Strain JG09 was an endophytic bacte-
ria; after a series of operations with the extracted DNA, such as PCR
and recombinant plasmid generation, the resulting gel electro-
phoresis ﬁgure showed the DNA length to be approximately
1,600 bp (Fig. 1). The obtained sequences were compared with
those in the GenBank database, and the results are shown in Table 1.
Phylogenetic analysis based on 16S rDNA gene sequences indi-
cated that the strain JG09 belongs to the genus Lucteibacter, and
endophyte JG09 is most closely related to Luteibacter sp. NORREL-
Li2 (99%), as seen in Fig. 2.
3.2. Effect of pH and culture medium on bioconversion of major
ginsenosides
The culture medium must meet the demand of microbial cell
growth and reproduction, because a large number of cells are
needed to generate large amounts of product. However, excessive
growth of cells will consume a large amount of nutrients; this
sometimes can affect the production capacity of the cell, resulting
in a decreased yield of product. So an appropriatemedia is essential
to a microbial strain.
In order to compare the effect of various media, strain JG09 was
cultured in the broths of H2O, R2A, PDB, LB, NB and LL, at an initial
pH of 7.0, mixingwith ginseng total saponins for 7 d. The suspension
were analyzed by TLC (Fig. 3). The cultures in PDB broth and LB broth
couldn’t convert major ginsenosides into C-K, but LL broth fer-
mented by JG09 efﬁciently convertedmajor ginsenosides into F2 and
C-K (Fig. 3), with the maximum degree of conversion of major gin-
senosides. This suggested that LL broth was not only suitable for the
growth of the strain JG09, but also for the production of F2 and C-K.
The pH value of the culture mediummainly causes the change in
the charge of the microorganism’s cytomembrane, and impacts the
ionization degree of nutrients, thereby affecting absorption of nu-
trients by the microbial cells. The pH also affects the biologically
active substances, such as enzyme activity. Different microbes have
different optimum pH values to adapt to the environment. The
optimum pH for microbial growth ranges from 4.0 to 9.0 in general.
Therefore, fermentation conditions, on the basis of the optimum
medium, at pH values of 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, and 10.0 were
investigated. The results indicated that the optimum pH of strain
JG09 was 4.0 (Fig. 4), which could maximize the content of gener-
ated minor ginsenosides F2 and C-K.
3.3. Bioconversion of major ginsenosides in ginseng total saponins
Under optimized fermention conditions, endophyte JG09 was
inoculated (3%, v/v) into a 250 mL Erlenmeyer’s ﬂask containing
100mL of sterilized liquid broth and 1.5 g ginseng total saponins for
a period of 10 d in a shaking incubator (30C, 150 rpm). Comparing
the change of saponin content before and after fermentation by
HPLC analysis, the content of protopanaxadiol-type major saponins
(Rb1, Rb2, Rc, and Rd) and protopanaxatriol-type major saponins
(Rg1 and Re) was generally decreased, and Rb1 was almost
completely transformed after 10 d of incubation. At the same time,
a signiﬁcant increase in the content of minor ginsenosides F2, C-K,
and Rh1 was observed (Fig. 5). To further analyze the source of
minor ginsenosides F2, C-K, and Rh1, major ginsenosides Rb1, Rb2,
Rc, Rd, and Rg1 were incubated with endophyte JG09; these stan-
dards of ginsenosides were then injected into HPLC.
3.4. Bioconversion pathways of major ginsenosides
In order to investigate the biotransformation pathway of major
ginsenosides into minor ginsenosides by endophyte JG09, the
Fig. 2. A 16S rDNA sequenced-based phylogenetic tree constructed by the Neighbor joining method. The numbers at the nodes are bootstrap values based on 1,000 replications.
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out by inoculating the ginsenoside into precultured suspensions,
followed by 7 d of incubation, during which different individual
samples from the same batch at different times were extracted. As
shown in Fig. 6, it is clear that endophyte JG09 could convert major
ginsenosides Rb1, Rb2, Rc, and Rd into minor ginsenosides F2 and
C-K and convert major ginsenoside Rg1 into minor ginsenoside
Rh1, based on the Rf values of standards.
The HPLC proﬁle of the reaction mixture of ginsenoside Rb1 and
the endophyte JG09 after incubation is shown in Fig. 7. In the HPLC
chromatogram, Rb1 was hydrolyzed by endophyte JG09 to produce
ginsenosides Rd, F2, and C-K, following 7 d of incubation. The
transformation products of ginsenosides Rb2, Rc, Rd, and Rg1 were
also analyzed by HPLC, which yielded the same results to the
ﬁndings of TLC (Fig. 6).
In the coculture of endophyte JG09 and ginsenoside Rb1,
endophyte JG09 converted ginsenoside Rb1 into C-K as well as Rd
and F2; the concentration of Rb1, Rd, F2, and C-K exhibited regularFig. 3. TLC analysis of metabolites of ginseng total saponins by endophyte JG09
cultured in different media: H2O (1), R2A (2), PDB (3), LB (4), NB (5), and LL (6). LB,
Luria-Bertani; LL, Lysogeny Liquid; NB, Nutrient Broth; PDB, Potato Dextrose Broth;
R2A, Agar medium S; S1 and S2, saponin standards.change with reaction time. From 4 h to 9 h, the content of ginse-
noside Rb1 and Rd gradually decreased and that of F2 and C-K
gradually increased. Ginsenoside Rd was completely converted af-
ter 9 h of incubation. It proved that the metabolite Rd was the
precursor of metabolite F2 and C-K. Fig. 7 shows that a peak area of
ginsenoside F2 increased after 4 h with the generation of ginse-
noside Rd, but decreased after 1 d of incubation. In the meantime,
the content of ginsenoside C-K signiﬁcantly increased after 1 d. The
peak area of ginsenoside F2 reached themaximumvaluewithin 9 h,
then the generation of ginsenoside C-K went into the rapidly
developing period and this stage should take a longer time. At last,
ginsenoside Rb1 was completely transformed and the corre-
sponding peak disappeared (Figs. 6A, 7). This suggested that Rb1
was converted in the following sequence: Rb1/Rd/F2/C-K, as
shown in the pathway in Fig. 8, by the different b-glucosidase from
endophyte JG09, consecutively hydrolyzing the terminal glucose
and inner glucose at the C-3 position, and terminal glucose at the C-
20 position.Fig. 4. TLC analysis of metabolites of ginseng total saponins by endophyte JG09
cultured at different pH’s of 3.0 (1), 4.0 (2), 5.0 (3), 6.0 (4), 7.0 (5), 8.0 (6), 9.0 (7), and
10.0 (8). S1 and S2, saponin standards.
Fig. 5. HPLC analysis of (A) ginseng total saponins and (B) fermented ginseng total saponins. The peaks correspond to ginsenoside Rg1, Re, Rh1, Rb1, Rc, Rb2, Rd, F2, and C-K,
respectively.
Fig. 6. Time-course TLC analyses of ginsenoside (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, and (E) Rg1 by endophyte JG09. C, blank sample; S1eS5, standard.
J Ginseng Res 2016;40:366e374370
Fig. 7. (A) HPLC proﬁle of the metabolites of ginsenoside Rb1 converted by endophyte JG09. (B) The content change of ginsenoside Rb1, Rd, F2, and C-K in the fermentation broth.
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version pathways of major ginsenosides Rb2, Rc, Rd, and Rg1 by
endophyte JG09, the results are as follows: Rb2/C-O/C-Y/C-K;
Rc/C-Mc1/C-Mc/C-K; Rd/F2/C-K; Rg1/Rh1, as shown in
the pathways in Figs. 8, 9.
3.5. Standard curve preparation and the maximum production rate
calculation for minor ginsenoside F2 and C-K
Fig.10 shows the standard curve of ginsenosides F2 and C-K by
plotting the area against the concentrations of ginsenosides F2 andC-K. Under these conditions, the full linear range of the assay was
extended from 0.003125 mg/mL to 0.75 mg/mL, as indicated in
Fig. 10. The linear correlation coefﬁcients R2 are 0.9985 and 0.9991,
respectively, so the standard curve can be used to calculate the
maximum yield of ginsenosides F2 and C-K during the trans-
formation. By using the molecular weight and the initial concen-
tration of Rb1, the theoretical yield of ginsenosides F2 and C-K were
calculated. Under optimum conditions, when Rb1 was added to the
culture broth of endophyte JG09, the content of ginsenosides F2 and
C-K could reach a maximum value in 7 d. In order to determine the
maximum production rate of minor ginsenosides F2 and C-K and
Fig. 8. Biotransformation pathway of ginsenosides Rb1, Rb2, Rc, and Rd by endophyte JG09.
J Ginseng Res 2016;40:366e374372assess the transformation effectiveness of endophyte JG09 to gin-
senoside Rb1, calculations were carried out using peak area and the
standard curve of ginsenosides. The results show that the
maximum production yield of ginsenoside F2 at 9 h reaches 94.53%,
the maximum production yield of ginsenoside C-K at 7 d reaches
66.34% (Table 2).
It is well known that P. ginseng has various ingredients including
ginsenosides and their derivatives. To date, ginsenosides have been
isolated and identiﬁed structurally from approximately 60 species
of the Panax genus [23]. Major ginsenosides such as Rb1, Rb2, Rc,
Rd, and Rg1 are present in greater abundance than any other gin-
senosides, however minor ginsenosides Rh1, F2, and C-K have
greater pharmacological effects such as tumor-suppressing,Fig. 9. Biotransformation pathway of ginantimetastatic, anticarcinogenic, hepatoprotective, neuro-
protective, immune-stimulating and vasodilating effects, which are
of great signiﬁcance for human health, though their content is
relatively low in ginseng. The anticancer activity of ginsenoside F2
was already applied and noticed [24,25]. Ginsenoside C-K is the
main pharmacologically active metabolite detected in blood after
the oral administration of major ginsenosides [26,27]. It has been
shown that ginsenoside C-K possesses various biological activities
in vivo or in vitro, such as antigenotoxic activity, antiallergic effect,
and antitumor activity [27]. In addition, ginsenoside C-K shows
potential hepatoprotective and anti-inﬂammatory activities and
the pharmacological effects of ginsenoside C-K appear to be
stronger than those of known minor ginsenosides and somesenosides Rg1 by endophyte JG09.
Fig. 10. Standard curve of ginsenoside F2 and C-K.
Table 2
Actual yield and production rate of ginsenoside F2 and C-K
Strain Ginsenoside F2 Ginsenoside C-K
Peak area
(9 h)
Actual mass (mg) Yield
(%)
Peak area
(7 d)
Actual mass
(mg)
Yield
(%)
JG09 872.3 0.06692 94.53 599.8 0.03323 66.34
L. Cui et al / Ginsenoside conversion by endophytes 373pharmaceutical drugs including diphenyl dimethyl bicarboxylate
and indomethacin [4,5,28e30]. There is a study showing that gin-
senoside Rb1 is hydrolyzed by intestinal microorganism in the body
and is changed to minor ginsenoside F2 [31]. Some studies have
looked for suitable microbes or enzymes that can transform major
ginsenosides into minor ginsenosides [3,12,32,33]. However, most
methods suffer from the fact that they are small scale, difﬁcult,
expensive, and low yielding, and there are only a few reports of
transforming major ginsenosides into minor ginsenosides by po-
tential resource endophytes.
In this study, we isolated 32 b-glucosidase-producing endophytes
from P. grandiﬂorum and identiﬁed endophyte JG09 as Lucteibacter
sp., which shows a strong ability to bioconvert major ginsenosides
into minor ginsenosides, as conﬁrmed by TLC and HPLC analysis.
This is the ﬁrst report of conversion of major ginsenosides to minor
ginsenosides by fermentation with P. grandiﬂorum endophytes. We
found that endophyte JG09 can hydrolyze protopanaxadiol ginse-
nosides Rb1, Rb2, Rc, and Rd intominor ginsenosides F2 and C-K, and
hydrolyze protopanaxatriol ginsenoside Rg1 into minor ginsenoside
Rh1 simultaneously. The method was simple, low cost, and high
yielding after optimizing the fermentation conditions. This new
ﬁnding could have great signiﬁcance in the research of ginsenosides,
and this biotransformation has great potential to be applied in the
preparation of minor ginsenosides F2 and C-K in the pharmaceutical
industry.Conﬂicts of interest
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